Download genomics, proteomics, and human psychiatric diseases

GENOMICS, PROTEOMICS, AND HUMAN PSYCHIATRIC DISEASES
NOVEMBER 7, 2003
UPDATE ON THE STANLEY BRAIN COLLECTION-A RESOURCE FOR THE
STUDY OF SCHIZOPHRENIA AND BIPOLAR DISORDER
Maree Webster, Michael Knable, Stanley Medical Research Institute, Bethesda, MD
MEASURING mRNA QUALITY IN POSTMORTEM HUMAN BRAIN TISSUE
Christine Miller, Stanley Division of Developmental Neurovirology, Johns Hopkins
University, Baltimore, MD
MITOCHONDRIAL DYSFUNCTION IN SCHIZOPHRENIA: EVIDENCE FOR
OXIDATIVE STRESS AND ABNORMAL GROWTH FACTOR SUPPORT
Sabine Bahn, Babraham Institute, United Kingdom
A PROTEOMICS APPROACH: TOWARDS THE UNDERSTANDING OF
SCHIZOPHRENIA AND BIPOLAR DISORDER
Janie Swatton, Babraham Institute, United Kingdom
ABERRANT GENE EXPRESSION IN HIPPOCAMPAL DENTATE GRANULE
AND CA3 NEURONS IN MULTIPLE GROUPS OF SCHIZOPHRENIC
PATIENTS
C. Anthony Altar, Psychiatric Genomics, Inc., Gaithersburg, MD
ANALYSIS OF GENE EXPRESSION, RNA EDITING, AND MITOCHONDRIAL
DNA DELETEION, IN THE STANLEY FOUNDATION BRAIN BANK SAMPLES
Tadafumi Kato, Brain Science Institute, Japan
RECENT FINDINGS OF A PROTEOMIC ANALYSIS OF ANTERIOR
CINGULATE CORTEX IN MAJOR PSYCHIATRIC DISORDERS AND FUTURE
DIRECTIONS IN THIS AREA
David Cotter, Michael Dunn, Royal College of Surgeons, Dublin, Ireland; Institute of
Psychiatry, London, UK
CANDIDATE GENE AND ARRAY-BASED METHODS IN PSYCHOSIS
RESEARCH
Paul Harrison, Oxford University, United Kingdom
VIRAL DETECTION ARRAYS: APPLICATION TO SCHIZOPHRENIA
Concha Goldberg, Stanley Medical Research Institute, Bethesda, MD
ASSOCIATION OF KEY SNP GENOTYPES WITH GENE EXPRESSION
PATTERNS IN THE OBRITOFRONTAL CORTEX OF NORMAL CONTROLS
Carlo Colantuoni, National Institute of Mental Health, National Institutes of Health,
Bethesda, MD
SCHIZOPHRENIA: PATTERNS OF DIFFERENTIAL GENE EXPRESSIONS IN
CORTICAL REGIONS
Marquis Vawter, Department of Psychiatry, University of California, Irvine, CA
EPIGENETIC STUDIES OF GENOMIC RETROELEMENTS IN MAJOR
PSYCHOSIS
Arturas Petronis, The Krembil Family Epigenics Laboratory, Center for Addiction &
Mental Health, Toronto, Ontario, Canada
DNA METHYLATION OF HTR2A, DRD2 & RELN GENES PROMOTERS IN
SCHIZOPHRENIA AND BIPOLAR DISORDER
Hamid Abdolmaleky, Harvard Medical School, Boston, MA
POSTERS
STUDIES OF METABOLIC DYSFUNCTIONS IN SCHIZOPHRENIA
Stephen Huffaker, Babraham Institute, United Kingdom
INTERPRETATION OF AFFYMETRIX GENE EXPRESSION RESULTS WITH
RESPECT TO PATIENT DEMOGRAPHICS
Margaret Ryan, Babraham Institute, United Kingdom
GENOMIC AND PROTEOMICS INVESTIGATIONS ON BLOOD CELLS FROM
SCHIZOPHRENIA PATIENTS
Prabakaran Sudhakaran, Babraham Institute, United Kingdom
QUANTITATIVE PCR VALIDATING AFFYMETRIX DATA-THE
TRANSCRIPT PROBLEM!
Michael Mimmack, Babraham Institute, United Kingdom
AMINO ACIDS, METABOLIC ABNORMALITIES IN SCHIZOPHRENIA
Dmetri Tkachev, Babraham Institute, United Kingdom
UNSE OF LASER CAPTURE MICRODISSECTION AND MICROARRAY
TECHNOLOGY TO IDENTIFY DRUG- AND DISEASE-ASOCIATED
TRANSCRIPTIONAL CHANGES IN HIPPOCAMPAL NEURONS
Vinod Charles, Jeffrey Brockman, Psychiatric Genomics, Inc., Gaithersburg, MD
ABNORMAL CARBOHYDRATE METABOLISM IN MOOD AND PSYCHOTIC
DISORDERS: LINKING PATHWAY FLUX TO PROTEONOMICS IN
POSTMORTEM BRAIN
William Regenold, University of Maryland, Department of Psychiatry, Baltimore, MD
DNA MICROARRAY STUDIES OF PRENATAL VIRALLY-EXPOSED MOUSE
BRAINS
S. Hossein Fatemi, Department of Psychiatry, University of Minnesota
DNA MICROARRAY ANALYSIS OF THE PREFRONTAL CORTEX IN
BIPOLAR DISORDER
K. Iwamoto, Laboratory for Molecular Dynamics of Mental Disorders, Brain Science
Institute, RIKEN, Saitama, Japan
ANALYZING EXPRESSION PROFILES OF VALPROATE REGULATED
GENES AND GENES INVOLVED IN BIPOLAR DISORDER
Jun-Feng Wang, Department of Psychiatry, University of Toronto, Canada
THE USE OF FLOW CYTOMETRIC BASED MULTIPLEX ASSAYS IN THE
ANALYSIS OF CYTOKINES AND GROWTH FACTORS FROM CSF AND
SERUM IN SCHIZOPHRENIA
Rachel Craddock, Babraham Institute, United Kingdom